These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 15896322)
1. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells. Machida Y; Chiba T; Takayanagi A; Tanaka Y; Asanuma M; Ogawa N; Koyama A; Iwatsubo T; Ito S; Jansen PH; Shimizu N; Tanaka K; Mizuno Y; Hattori N Biochem Biophys Res Commun; 2005 Jun; 332(1):233-40. PubMed ID: 15896322 [TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation]. Hattori N; Machida Y; Noda K Rinsho Shinkeigaku; 2005 Nov; 45(11):905-7. PubMed ID: 16447759 [TBL] [Abstract][Full Text] [Related]
4. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511 [TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533 [TBL] [Abstract][Full Text] [Related]
6. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease. Yasuda T; Mochizuki H Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696 [TBL] [Abstract][Full Text] [Related]
7. Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease. Yamada M; Mizuno Y; Mochizuki H Hum Gene Ther; 2005 Feb; 16(2):262-70. PubMed ID: 15761265 [TBL] [Abstract][Full Text] [Related]
8. Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease. Baptista MJ; Cookson MR; Miller DW Neuroscientist; 2004 Feb; 10(1):63-72. PubMed ID: 14987449 [TBL] [Abstract][Full Text] [Related]
9. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Yang Y; Nishimura I; Imai Y; Takahashi R; Lu B Neuron; 2003 Mar; 37(6):911-24. PubMed ID: 12670421 [TBL] [Abstract][Full Text] [Related]
10. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease]. Hattori N Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506 [TBL] [Abstract][Full Text] [Related]
11. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease. Haywood AF; Staveley BE BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075 [TBL] [Abstract][Full Text] [Related]
12. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Moussa CE; Wersinger C; Tomita Y; Sidhu A Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920 [TBL] [Abstract][Full Text] [Related]
13. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198 [TBL] [Abstract][Full Text] [Related]
15. [Parkinson's disease: what have we learned from the genes responsible for familial forms?]. Corti O; Brice A Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396 [TBL] [Abstract][Full Text] [Related]
16. The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects. Lim KL; Dawson VL; Dawson TM Ann N Y Acad Sci; 2003 Jun; 991():80-92. PubMed ID: 12846976 [TBL] [Abstract][Full Text] [Related]